Home » Topics » BioWorld Science

BioWorld Science
RSS

Orally bioavailable LTD4 antagonists from Menarini

Sep. 27, 1996

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

E. Merck reports PDE IV inhibitors

Sep. 27, 1996

New cough/cold remedy introduced in the U.S.

Sep. 27, 1996

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Takeda's CNS pipeline updated

Sep. 27, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...